Experimental Yersinia-triggered reactive arthritis: Effect of a 3-week course of ciprofloxacin

British Journal of Rheumatology

Volumn 36, Issue 5, 1997, Pages 541-546

  Zhang, Y ^a,b   Toivanen, A ^a   Toivanen, P ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY   (Finland)

Author keywords

Ciprofloxacin; Reactive arthritis; Yersinia

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FECES; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REACTIVE ARTHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION; YERSINIA ENTEROCOLITICA;

EID: 0030824881     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.5.541     Document Type: Article

References (25)

1. Lauhio A, Leirisalo-Repo M, Lähdevirta J, Saikku P, Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991;34:6-14.
2. Lauhio A, Sorsa T, Lindy O et al. The anticollagenolytic potential of lymecycline in the long-term treatment of reactive arthritis. Arthritis Rheum 1992;35:195-8.
3. Bardin T, Enel C, Cornelis F et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992;35:190-4.
4. Schachter J, Barnes MG, Jones JP Jr, Engleman EP, Meyer KF. Isolation of Bedsoniae from the joints of patients with Reiter's syndrome. Proc Soc Exp Biol Med 1966;122:283-5.
5. Vilppula AH, Yli-Kerttula UI, Ahlroos AK, Terho PE. Chlamydial isolations and serology in Reiter's syndrome. Scand J Rheumatol 1981;10:181-5.
6. Hammer M, Nettelnbreker E, Hopf S, Schmitz E, Pörschke K, Zeidler H. Chlamydial rRNA in the joints of patients with Chlamydia-induced arthritis and undifferentiated arthritis. Clin Exp Rheumatol 1992;10:63-6.
7. Rahman MU, Cheema MA, Schumacher HR, Hudson AP. Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum 1992;35:521-9.
8. Taylor-Robinson D, Gilroy CB, Thomas BJ, Keat AC. Detection of Chlamydia trachomatis DNA in joints of reactive arthritis patients by polymerase chain reaction. Lancet 1992;340:81-2.
9. Nanagara R, Li F, Beutler A, Hudson A, Schumacher HR Jr. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes. Suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum 1995;38:1410-7.
10. Bas S, Griffais R, Kvien T, Glennås A, Melby K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995;38:1005-13.
11. Viitanen AM, Arstila TP, Lahesmaa R, Granfors K, Skurnik M, Toivanen P. Application of the polymerase chain reaction and immunofluorescence techniques to the detection of bacteria in Yersinia-triggered reactive arthritis. Arthritis Rheum 1991;34:89-96.
12. Nikkari S, Merilahti-Palo R, Saario R et al. Yersinia-triggered reactive arthritis: use of polymerase chain reaction and immunocytochemical staining in the detection of bacterial components from synovial specimens. Arthritis Rheum 1992;35:682-7.
13. Toivanen A, Yli-Kerttula T, Luukkainen R, Merilahti-Palo R, Granfors K, Seppälä J. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993;11:301-7.
14. Leirisalo-Repo M. Are antibiotics of any use in reactive arthritis? APMIS 1993;101:575-81.
15. Locht H, Kihlström E, Lindström FD. Reactive arthritis after Salmonella among medical doctors - study of an outbreak. J Rheumatol 1993;20:845-8.
16. Leirisalo-Repo M. Treatment of reactive arthritis. Rheumatol Eur 1995;24:20-2.
17. Zhang Y, Gripenberg-Lerche C, Söderström K-O, Toivanen A, Toivanen P. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum 1996;39:1238-43.
18. Toivanen A, Merilahti-Palo R, Gripenberg C, Lahesmaa-Rantala R, Söderström K-O, Jaakkola U-M. Yersinia-associated arthritis in the rat: experimental model for human reactive arthritis? Acta Pathol Microbiol Immunol Scand (C) 1986;94:261-9.
19. Hill JL, Yu DTY. Development of an experimental animal model for reactive arthritis by Yersinia enterocolitica infection. Infect Immun 1987;55:721-6.
20. Merilahti-Palo R, Gripenberg-Lerche C, Söderström K-O, Toivanen P. Long term follow up of SHR rats with experimental yersinia associated arthritis. Ann Rheum Dis 1992;51:91-6.
21. Gripenberg-Lerche C, Toivanen P. Yersinia associated arthritis in SHR rats: effect of the microbial status of the host. Ann Rheum Dis 1993;52:223-8.
22. Gripenberg-Lerche C, Skurnik M, Zhang L, Söderström K-O, Toivanen P. Role of YadA in arthritogenicity of Yersinia enterocolitica serotype O:8; experimental studies with rats. Infect Immun 1994;62:5568-75.
23. Gripenberg-Lerche C, Skurnik M, Toivanen P. Role of YadA-mediated collagen binding in arthritogenicity of Yersinia enterocolitica serotype O:8: experimental studies with rats. Infect Immun 1995;63:3222-6.
24. Toivanen A, Granfors K, Lahesmaa-Rantala R, Leino R, Ståhlberg T, Vuento R. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects. Immunol Rev 1985;86:47-70.
25. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7:290-302.